Skip Navigation


JAC Advance Access originally published online on May 10, 2005
Journal of Antimicrobial Chemotherapy 2005 55(6):928-937; doi:10.1093/jac/dki122
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
55/6/928    most recent
dki122v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Landgren, M.
Right arrow Articles by Kahlmeter, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landgren, M.
Right arrow Articles by Kahlmeter, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions{at}oupjournals.org

Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries

M. Landgren1, H. Odén1, I. Kühn2, A. Österlund1 and G. Kahlmeter1,*

1 Department of Clinical Microbiology, Central Hospital, SE-351 85 Växjö, Sweden; 2 Microbiology and Tumor Biology Center, Karolinska Institute, SE-171 77 Stockholm, Sweden


* Corresponding author. Email: gunnar.kahlmeter{at}ltkronoberg.se

Objectives: In the recently published ECO·SENS survey, the antimicrobial susceptibility of Escherichia coli from urinary tract infections in women in 16 European countries and Canada was investigated. This study reports the diversity among these E. coli.

Methods: The 2481 E. coli, typed with the PhenePlateTM (PhP) System utilizing the dynamics and end result of 11 biochemical reactions in a microplate system, were clustered and the Simpson's index of diversity calculated.

Results: Seventy-four Common PhP Types (CT) comprising 2067 isolates and 414 Single Types (Si) were identified. Of these, 916 isolates (37%) belonged to one of the four most frequent CT (arbitrarily numbered CT48, 10, 26 and 20). CT48 with 400 isolates and 11 different susceptibility patterns, was widely disseminated across Europe and Canada and was the most frequent type in 13 countries and the second most frequent in the remaining four countries. Sixty-four per cent of the E. coli were susceptible to all eight investigated antimicrobials (CT48: 73%, CT10: 77%, CT26: 62% and CT20: 37%). Forty-six different susceptibility patterns were seen, the three most common being isolated resistance to ampicillin, resistance to ampicillin and trimethoprim, and isolated resistance to trimethoprim. Multiresistance, here defined as resistance to four or more of the investigated antibiotics, was distributed among E. coli belonging to several PhP types.

Conclusions: There was no obvious correlation between the phenotypes identified with the PhP System and the susceptibility pattern. The data did not indicate clonal dissemination within or between countries as a major reason for differences in antimicrobial resistance rates.

Keywords: E. coli , clonality , typing , PhP , UTI


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Antimicrob ChemotherHome page
M. Sundqvist, P. Geli, D. I. Andersson, M. Sjolund-Karlsson, A. Runehagen, H. Cars, K. Abelson-Storby, O. Cars, and G. Kahlmeter
Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use
J. Antimicrob. Chemother., February 1, 2010; 65(2): 350 - 360.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
D. Reyes, S. Vilchez, M. Paniagua, P. Colque, A. Weintraub, R. Mollby, and I. Kuhn
Diversity of intestinal Escherichia coli populations in Nicaraguan children with and without diarrhoea
J. Med. Microbiol., December 1, 2009; 58(12): 1593 - 1600.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. Sundqvist and G. Kahlmeter
Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database
J. Antimicrob. Chemother., May 1, 2007; 59(5): 913 - 918.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
H. E. Sidjabat, K. M. Townsend, M. Lorentzen, K. S. Gobius, N. Fegan, J. J.-C. Chin, K. A. Bettelheim, N. D. Hanson, J. C. Bensink, and D. J. Trott
Emergence and spread of two distinct clonal groups of multidrug-resistant Escherichia coli in a veterinary teaching hospital in Australia.
J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1125 - 1134.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
M. T. Blahna, C. A. Zalewski, J. Reuer, G. Kahlmeter, B. Foxman, and C. F. Marrs
The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada
J. Antimicrob. Chemother., April 1, 2006; 57(4): 666 - 672.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.